<DOC>
	<DOCNO>NCT01165021</DOCNO>
	<brief_summary>The purpose trial ass well combination pemetrexed cisplatin reduce tumor size .</brief_summary>
	<brief_title>A Study Pemetrexed/Cisplatin Pre-operative Treatment Early Stage Nonsquamous Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>Nonsquamous NonSmall Cell Lung Cancer confirm tissue biopsy Stage IIIAN2 disease ( T1aN2 , T1bN2 , T2aN2 , T2bN2 , T3N2 ) Tumor consider potentially resectable Good performance status ( score 0 1 ) accord Eastern Cooperative Oncology Group scale ( ECOG ) No prior therapy lung cancer Measurable disease accord version 1.1 Response Evaluation Criteria Solid Tumors ( RECIST ) Criteria Life expectancy least 6 month Organs function well ( bone marrow reserve , liver , kidney , lung ) Signed Informed Consent Women must surgically sterile , postmenopausal , compliant medically approve contraceptive regimen ( example , intrauterine device , birth control pill , barrier device ) 6 month last dose study drug ; must negative pregnancy test within 7 day study enrollment ; must breastfeed . Men must surgically sterile , compliant contraceptive regimen 6 month last dose study drug . Be fit surgery time enrollment Receiving receive investigational drug device within last 30 day Have previously complete withdrawn study study investigate pemetrexed Serious concomitant systemic disorder Serious cardiac condition , myocardial infarction within 6 month , angina , heart disease Receiving concurrent administration anticancer therapy Have receive recent ( within 30 day enrollment ) receive concurrent yellow fever vaccination Inability unwillingness take Pemetrexed supplementation/premedication ( folic acid , vitamin B12 , corticosteroid ) Inability interrupt aspirin nonsteroidal antiinflammatory agent , aspirin dose less equal 1.3 gram per day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>